BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31086640)

  • 1. Does pre-diagnostic loss to follow-up among presumptive TB patients differ by type of health facility? An operational research from Hwange, Zimbabwe in 2017.
    Padingani M; Kumar A; Tripathy JP; Masuka N; Khumalo S
    Pan Afr Med J; 2018; 31():196. PubMed ID: 31086640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriologically confirmed pulmonary tuberculosis patients: Loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012-2016.
    Mugauri H; Shewade HD; Dlodlo RA; Hove S; Sibanda E
    Int J Infect Dis; 2018 Nov; 76():6-13. PubMed ID: 30030177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where, when, and how many tuberculosis patients are lost from presumption until treatment initiation? A step by step assessment in a rural district in Zimbabwe.
    Murongazvombo AS; Dlodlo RA; Shewade HD; Robertson V; Hirao S; Pikira E; Zhanero C; Taruvinga RK; Andifasi P; Tshuma C
    Int J Infect Dis; 2019 Jan; 78():113-120. PubMed ID: 30368019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How well does the process of screening and diagnosis work for HIV-infected persons identified with presumptive tuberculosis who are attending HIV care and treatment clinics in Harare city, Zimbabwe?
    Takarinda KC; Choto R; Sandy C; Apollo T; Duri C; Dube F; Mpofu A; Timire C; Mugurungi O; Makaza V; Tapera R; Harries AD
    Trans R Soc Trop Med Hyg; 2018 Oct; 112(10):450-457. PubMed ID: 30032237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engagement of public and private medical facilities in tuberculosis care in Myanmar: contributions and trends over an eight-year period.
    Nwe TT; Saw S; Le Win L; Mon MM; van Griensven J; Zhou S; Chinnakali P; Shah S; Thein S; Aung ST
    Infect Dis Poverty; 2017 Sep; 6(1):123. PubMed ID: 28859677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.
    Zawedde-Muyanja S; Musaazi J; Manabe YC; Katamba A; Nankabirwa JI; Castelnuovo B; Cattamanchi A
    PLoS One; 2020; 15(11):e0241611. PubMed ID: 33206650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV care among patients with presumptive tuberculosis in Masvingo district of Zimbabwe, 2017: how well are we doing?
    Ndudzo C; Tripathy JP; Tauro F; Sibanda C; Chiramba M; Shamu A; Masinire K; Muchengwa T; Kumar AM
    Pan Afr Med J; 2019; 33():158. PubMed ID: 31565120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing TB case detection: experience in offering upfront Xpert MTB/RIF testing to pediatric presumptive TB and DR TB cases for early rapid diagnosis of drug sensitive and drug resistant TB.
    Raizada N; Sachdeva KS; Nair SA; Kulsange S; Gupta RS; Thakur R; Parmar M; Gray C; Ramachandran R; Vadera B; Ekka S; Dhawan S; Babre A; Ghedia M; Alavadi U; Dewan P; Khetrapal M; Khanna A; Boehme C; Paramsivan CN
    PLoS One; 2014; 9(8):e105346. PubMed ID: 25140877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis diagnostic and treatment practices in private sector: Implementation study in an Indian city.
    Chadha VK; Bhalla BB; Ramesh SB; Gupta J; Nagendra N; Padmesh R; Ahmed J; Srivastava RK; Jaiswal RK; Praseeja P
    Indian J Tuberc; 2018 Oct; 65(4):315-321. PubMed ID: 30522619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculosis case management and treatment outcome: assessment of the effectiveness of Public-Private Mix of tuberculosis programme in Kaduna State, Nigeria.
    Gidado M; Ejembi CL
    Ann Afr Med; 2009; 8(1):25-31. PubMed ID: 19763003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda.
    Zawedde-Muyanja S; Katamba A; Cattamanchi A; Castelnuovo B; Manabe YC
    BMC Public Health; 2020 Dec; 20(1):1855. PubMed ID: 33272226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Where are patients missed in the tuberculosis diagnostic cascade? A prospective cohort study in Ghana.
    Der JB; Grint D; Narh CT; Bonsu F; Grant AD
    PLoS One; 2020; 15(3):e0230604. PubMed ID: 32191768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing tuberculosis management under public and private healthcare providers: Victoria, Australia, 2002-2015.
    Dale KD; Tay EL; Trauer JM; Trevan PG; Denholm JT
    BMC Infect Dis; 2017 May; 17(1):324. PubMed ID: 28468641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis services and treatment outcomes in private and public health care facilities in Thailand, 2004-2006.
    Chengsorn N; Bloss E; Anekvorapong R; Anuwatnonthakate A; Wattanaamornkiat W; Komsakorn S; Moolphate S; Limsomboon P; Kaewsa-ard S; Nateniyom S; Kanphukiew A; Varma JK
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):888-94. PubMed ID: 19555540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain
    Timire C; Sandy C; Kumar AMV; Ngwenya M; Murwira B; Takarinda KC; Harries AD
    Int J Infect Dis; 2019 Apr; 81():236-243. PubMed ID: 30776546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TB case notification by private health-sector; retrospective study in 13 metro districts of Pakistan.
    Faisal S; Abbas A; Haider G; Rab A; Farough K
    J Pak Med Assoc; 2018 Nov; 68(11):1666-1671. PubMed ID: 30410147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.
    Raizada N; Khaparde SD; Rao R; Kalra A; Sarin S; Salhotra VS; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Nair SA; Huddart S; Tripathi R; Surya Prakash CH; Saha BK; Denkinger CM; Boehme C
    PLoS One; 2018; 13(8):e0202085. PubMed ID: 30161142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    Kalra A; Parija D; Raizada N; Sachdeva KS; Rao R; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Sheladia KN; Rao R; Vasundhara N; S A; A R N; Azeem A; Chhajlani V; Khurana J; Das NJ; Choudhury B; Nair SA; Mall S; Sen R; Chadha SS; Denkinger CM; Boehme C; Sarin S
    PLoS One; 2020; 15(8):e0236057. PubMed ID: 32756559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe.
    Ndlovu Z; Fajardo E; Mbofana E; Maparo T; Garone D; Metcalf C; Bygrave H; Kao K; Zinyowera S
    PLoS One; 2018; 13(3):e0193577. PubMed ID: 29499042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.